HemaSphere (Jun 2022)

P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA

  • M.-A. Dimopoulos,
  • K. Amaador,
  • M. C. Minnema,
  • K. Nasserinejad,
  • M. Kap,
  • E. Kastritis,
  • M. Gavriatopoulou,
  • W. Kraan,
  • M. E. D. Chamuleau,
  • D. Deeren,
  • L. Tick,
  • J. K. Doorduijn,
  • F. Offner,
  • L. H. Böhmer,
  • R. D. Liu,
  • S. T. Pals,
  • J. M. Vos,
  • M. J. Kersten

DOI
https://doi.org/10.1097/01.HS9.0000847288.62394.e8
Journal volume & issue
Vol. 6
pp. 995 – 996

Abstract

Read online

No abstracts available.